Research Article

An Evaluation of the Genotoxicity and Subchronic Oral Toxicity of Synthetic Curcumin

Table 2

Mutagenicity assay: mean revertant frequency in the presence of metabolic activation system (5% v/v, S9).

Concentration (g/plate)TA1537TA1535TA98TA100TA102
Mean ± SD#Mean ± SD#Mean ± SD#Mean ± SD#Mean ± SD#

Vehicle Control 0.013.33 ± 0.58NA14.00 ± 3.61NA32.00 ± 9.54NA107.67 ± 5.13NA289.33 ± 64.38NA

5.013.67 ± 5.131.0312.00 ± 1.000.8622.00 ± 4.360.69107.00 ± 6.560.99302.00 ± 20.881.04

16.015.00 ± 0.001.1311.67 ± 2.520.8328.67 ± 6.810.90114.67 ± 4.511.07340.67 ± 37.221.18

50.014.00 ± 1.001.0511.67 ± 2.890.8323.67 ± 2.520.74116.00 ± 35.091.08362.67 ± 25.171.25

160.013.67 ± 2.081.0313.33 ± 2.080.9523.00 ± 4.360.72121.00 ± 9.641.12280.67 ± 33.490.97

500.011.67 ± 3.790.8811.33 ± 1.530.8124.00 ± 5.570.7588.33 ± 6.660.82353.33 ± 30.551.22

1600.011.00 ± 1.730.8310.00 ± 3.000.7136.33 ± 17.621.65101.67 ± 22.190.95322.67 ± 44.061.12

2AA (20.0)1026.67 ± 140.1277.021036.67 ± 130.5174.051180.00 ± 60.0036.881533.33 ± 135.0314.241740.00 ± 87.186.01

2AA, 2-aminoanthracene; NA, not applicable; SD, standard deviation; #, relative fold values as compared to Vehicle Control.
Note. Vehicle is dimethyl sulfoxide; 2AA is the positive control.